CDIO
Cardio Diagnostics Holdings, Inc.
CDIO
Cardio Diagnostics Holdings, Inc.
$ 2
-
1 of 5 dimensions have missing or inapplicable inputs and score 0. The total includes these dimensions.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
| Asset | Price | Div. Yield |
|---|